NCT00404053View on ClinicalTrials.gov

Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2004

Study Completion Date

November 30, 2006

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Clopidogrel

All Listed Sponsors
lead

Shenyang Northern Hospital

OTHER

NCT00404053 - Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation | Biotech Hunter | Biotech Hunter